COLUMVI 2,5 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Roche Registration Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 7469bf67244b999d
Drug Cima Aemps Name: COLUMVI 2,5 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1231742001
Holder Company Name: Roche Registration Gmbh
Marketing Company Name: Roche Farma S.A.
Holder Company Detail Path: /organization/roche-registration-gmbh
Authorization Date: 2023-07-13
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2,5 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Roche Registration Gmbh
Company Detail Path: /organization/roche-registration-gmbh

GLOFITAMAB

2,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 13, 2023

Approval ID

7469bf67244b999d

Type

Standard